Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Accounts Payables (2019 - 2025)

Korro Bio's Accounts Payables history spans 7 years, with the latest figure at $1.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables fell 58.64% year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Dec 2025, down 58.64%, and an annual FY2025 reading of $1.7 million, down 58.64% over the prior year.
  • Accounts Payables for Q4 2025 was $1.7 million at Korro Bio, down from $2.3 million in the prior quarter.
  • The five-year high for Accounts Payables was $7.3 million in Q4 2023, with the low at $338000.0 in Q3 2023.
  • Average Accounts Payables over 5 years is $3.7 million, with a median of $3.7 million recorded in 2021.
  • Year-over-year, Accounts Payables plummeted 91.57% in 2023 and then soared 1660.36% in 2024.
  • Tracing KRRO's Accounts Payables over 5 years: stood at $2.7 million in 2021, then dropped by 5.2% to $2.6 million in 2022, then surged by 179.46% to $7.3 million in 2023, then tumbled by 45.16% to $4.0 million in 2024, then plummeted by 58.64% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Accounts Payables are $1.7 million (Q4 2025), $2.3 million (Q3 2025), and $5.2 million (Q2 2025).